Fasting biochemical evaluation and liver imaging revealed persisting metabolic dyslipidemia, fatty liver, raised plasma testosterone and insulin, and relatively normal adiponectin and leptin (Table 2). The gene discussed is INS; the disease is metabolic syndrome.